Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review
Olivia R. Phillips, David Baguley, Stephanie Pearson, et al.
Journal of Cancer Survivorship (2023) Vol. 17, Iss. 1, pp. 40-58
Open Access | Times Cited: 20

Showing 20 citing articles:

Association between urinary metals and prostate-specific antigen in aging population with depression: a cross-sectional study
Liquan Ren, Yue Zhang, Jinyi Wu
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 4
Oncologists’ views on ototoxicity monitoring in head and neck cancer patients: A South Indian qualitative study
Varsha Shankar, Jayashree Seethapathy, Satish Srinivas, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0312847-e0312847
Open Access
STM2457 decreases m6A methylation to reduce cisplatin-induced ototoxicity via MAPK signaling
Jiahao Liao, Xingxing Wu, Qingdong Zeng, et al.
Biochemical Pharmacology (2025), pp. 116820-116820
Closed Access
Platinum-Induced Ototoxicity in Pediatric Patients with Solid Tumors: Younger and Male Children are More Susceptible
Jie Bai, Song Yao, Xuetong Wang, et al.
International Journal of Pediatric Otorhinolaryngology (2025), pp. 112292-112292
Closed Access
Ototoxicité des traitements systémiques des tumeurs malignes et principes de diagnostic et de prise en charge
François-Régis Ferrand, Fabrice Giraudet, J. Nevoux, et al.
Bulletin du Cancer (2025)
Closed Access
Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model
Matthew A. Ingersoll, Richard D. Lutze, Chithra K. Pushpan, et al.
JCI Insight (2023) Vol. 8, Iss. 24
Open Access | Times Cited: 8
Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective
Sophie D. Fosså, Hege Sagstuen Haugnes, Alv A. Dahl, et al.
Annals of Oncology (2023) Vol. 34, Iss. 12, pp. 1165-1174
Closed Access | Times Cited: 5
Role of a mental health physician in the management of oncology patients: a case vignette and the need for collaboration
Aishatu Yusha’u Armiya’u, Yusuf Akande
Frontiers in Health Services (2024) Vol. 4
Open Access | Times Cited: 1
Strengthening cancer care through the inclusion of audiological services
Nabeelah Nagdee, Victor de Andrade
South African Health Review (2024) Vol. 26
Closed Access | Times Cited: 1
Incidence of cisplatin-induced ototoxicity in adult cancer patients based on audiometric confirmation of patient self-report
François Voruz, Aurélie Vuilleumier, Denis Migliorini, et al.
Frontiers in Audiology and Otology (2023) Vol. 1
Open Access | Times Cited: 3
Assessing quality of life in childhood cancer survivors at risk for hearing loss: a comparison of HEAR-QL and PROMIS measures
Anne Spence, Allison J. L’Hotta, Susan S. Hayashi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Investigation of Noise Induced Hearing Loss Among Power Loom Industry Workers in Tamil Nadu, India
S. Shankar, Abbas Ganesan, Naveenkumar Raju, et al.
Indian Journal of Otolaryngology and Head & Neck Surgery (2024) Vol. 76, Iss. 6, pp. 5531-5541
Closed Access
Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment
Katharine Fernandez, Alex E. Hoetink, Dawn Konrad‐Martin, et al.
Ear and Hearing (2024)
Closed Access
Transcriptome analysis revealed the genes and major pathways involved in prunetrin treated hepatocellular carcinoma cells
Abuyaseer Abusaliya, Hun Hwan Kim, Preethi Vetrivel, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Cisplatin-Induced Hearing Loss, Oxidative Stress, and Antioxidants as a Therapeutic Strategy—A State-of-the-Art Review
Olaf Rose, Tim Croonenberg, Stephanie Clemens, et al.
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1578-1578
Open Access
How do patients with head and neck cancer and low skeletal muscle mass experience cisplatin-based chemoradiotherapy? A qualitative study
Anouk W. M. A. Schaeffers, Maartje A. van Beers, Lot A. Devriese, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 11
Open Access
Ototoxicity associated with hematopoietic stem cell transplantation; what are the risk factors?
Eray Uzunoğlu, M Akalin, Zübeyde Nur Özkurt, et al.
Acta Oto-Laryngologica (2024), pp. 1-5
Closed Access
Introduction to the special section: treatment-related hearing loss and its impact on cancer survivors
Kathleen M. Castro, Emily S. Tonorezos
Journal of Cancer Survivorship (2023) Vol. 17, Iss. 1, pp. 1-3
Open Access | Times Cited: 1
OTOTOXIC EFFECTS OF ANTINEOPLASTIC DRUGS: A SYSTEMATIC REVIEW
Desnita Monica
Journal of Advance Research in Medical & Health Science (ISSN 2208-2425) (2023) Vol. 9, Iss. 8, pp. 8-13
Open Access | Times Cited: 1
Advances in Otorhinolaryngological Community Services: The HearWHO App in Southern Nigeria
Immaculata Ogechi Akpalaba, OKHAWERE Imouokhome Martin, Raphael Uchenna Enyinnaya Akpalaba, et al.
(2023)
Open Access | Times Cited: 1
Adaptation and Validation of the Turkish Version of the International Tinnitus Inventory
Gurbet İpek Şahin Kamışlı, Gözde Bayramoğlu Çabuk, Songül Aksoy
Turkish Archives of Otorhinolaryngology (2023) Vol. 61, Iss. 3, pp. 109-117
Open Access
Page 1

Scroll to top